Drop in Prozac sales hits Eli Lilly profits

Eli Lilly has revealed a 7% drop in profits following falling sales of its Prozac anti-depressant drug.

The company posted third quarter earnings of £500 million, or 66 cents per share, compared with £540m, or 71 cents, the year-earlier quarter.